doi:10.3969/j.issn.1004-583X.2022.10.014

Abstract

CLC Number:

R543.5

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.10.014

https://huicui.hebmu.edu.cn/EN/Y2022/V37/I10/950

References 25

[1]	Curi R, de Siqueira Mendes R, de Campos Crispin LA, et al. A past and present overview of macrophage metabolism and functional outcomes[J]. Clin Sci (Lond), 2017, 131(12):1329-1342. doi: 10.1042/CS20170220 pmid: 28592702
[2]	Kundi H, Kiziltunc E, Cetin M, et al. Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease[J]. Herz, 2016, 41(6):523-529. doi: 10.1007/s00059-015-4393-1 pmid: 26753671
[3]	Yang J, Zhang L, Yu C, et al. Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases[J]. Biomark Res, 2014, 2(1):1. doi: 10.1186/2050-7771-2-1 pmid: 24398220
[4]	Kim KW, Ivanov S, Williams JW. Monocyte recruitment, specification, and function in atherosclerosis[J]. Cells, 2020, 10(1):15. doi: 10.3390/cells10010015 URL
[5]	Nozawa N, Hibi K, Endo M, et al. Association between circulating monocytes and coronary plaque progression in patients with acute myocardial infarction[J]. Circ J, 2010, 74(7):1384-1391. pmid: 20467155
[6]	Jaipersad AS, Lip GY, Silverman S, et al. The role of monocytes in angiogenesis and atherosclerosis[J]. J Am Coll Cardiol, 2014, 63(1):1-11. doi: 10.1016/j.jacc.2013.09.019 pmid: 24140662
[7]	Ossoli A, Remaley AT, Vaisman B, et al. Plasma-derived and synthetic high-density lipoprotein inhibit tissue factor in endothelial cells and monocytes[J]. Biochem J, 2016, 473(2):211-219. doi: 10.1042/BJ20151000 pmid: 26556891
[8]	Usta A, Avci E, Bulbul CB, et al. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome[J]. Reprod Biol Endocrinol, 2018, 16(1):34. doi: 10.1186/s12958-018-0351-0 URL
[9]	Kontush A, Lindahl M, Lhomme M, et al. Structure of HDL: Particle subclasses and molecular components[J]. Handb Exp Pharmacol, 2015, 224:3-51. doi: 10.1007/978-3-319-09665-0_1 pmid: 25522985
[10]	Calabresi L, Gomaraschi M, Franceschini G. High-density lipoprotein quantity or quality for cardiovascular prevention?[J]. Curr Pharm Des, 2010, 16(13):1494-1503. doi: 10.2174/138161210791050960 URL
[11]	Ganjali S, Momtazi AA, Banach M, et al. HDL abnormalities in familial hypercholesterolemia: Focus on biological functions[J]. Prog Lipid Res, 2017, 67:16-26. doi: S0163-7827(17)30011-5 pmid: 28506805
[12]	Acikgoz N, Kurtoˇglu E, Yagmur J, et al. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in behçet disease[J]. Angiology, 2018, 69(1):65-70. doi: 10.1177/0003319717704748 pmid: 28421814
[13]	Murphy AJ, Akhtari M, Tolani S, et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice[J]. J Clin Invest, 2011, 121(10):4138-4149. doi: 10.1172/JCI57559 URL
[14]	Bolayir A, Gokce SF, Cigdem B, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients[J]. Neurol Neurochir Pol, 2018, 52(2):150-155. doi: S0028-3843(17)30104-4 pmid: 28864326
[15]	Kadihasanoglu M, Karabay E, Yucetas U, et al. Relation between monocyte to high-density lipoprotein cholesterol ratio and presence and severity of erectile dysfunction[J]. Aktuelle Urol, 2018, 49(3):256-261. doi: 10.1055/s-0042-123163 URL
[16]	You S, Zhong C, Zheng D, et al. Monocyte to HDL cholesterol ratio is associated with discharge and 3-month outcome in patients with acute intracerebral hemorrhage[J]. J Neurol Sci, 2017, 372:157-161. doi: S0022-510X(16)30717-1 pmid: 28017204
[17]	Canpolat U, Çetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation[J]. Clin Appl Thromb Hemost, 2016, 22(5):476-482. doi: 10.1177/1076029615594002 URL
[18]	Ganjali S, Gotto AM Jr, Ruscica M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases[J]. J Cell Physiol, 2018, 233(12):9237-9246. doi: 10.1002/jcp.27028 pmid: 30076716
[19]	Akboga MK, Yayla C, Balci KG, et al. Relationship between serum albumin level and monocyte-to-high-density lipoprotein cholesterol ratio with saphenous vein graft disease in coronary bypass[J]. Thorac Cardiovasc Surg, 2017, 65(4):315-321. doi: 10.1055/s-0036-1582260 pmid: 27111497
[20]	黄朝发, 李菊香, 颜素娟, 等. 单核细胞/高密度脂蛋白胆固醇比值与急性心肌梗死患者介入术后慢血流或无复流的相关性分析[J]. 中国循环杂志, 2017, 32(8):737-741.
[21]	Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome[J]. Heart Lung Circ, 2016, 25(11):1077-1086. doi: S1443-9506(16)30047-6 pmid: 27118231
[22]	陈洁霞, 李结华, 唐海沁. 单核细胞与高密度脂蛋白比值和颈动脉粥样硬化斑块稳定性的相关性研究[J]. 中国临床保健杂志, 2017, 20(4):383-385.
[23]	Wang HY, Shi WR, Yi X, et al. Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: Insights from a population-based Chinese cohort[J]. Lipids Health Dis, 2019, 18(1):127. doi: 10.1186/s12944-019-1076-6 URL
[24]	Li Y, Chen D, Sun L, et al. Monocyte/high-density lipoprotein ratio predicts the prognosis of large artery atherosclerosis ischemic stroke[J]. Front Neurol, 2021, 12:769217. doi: 10.3389/fneur.2021.769217 URL
[25]	Liu Z, Fan Q, Wu S, et al. Associations of monocytes and the monocyte/high-density lipoprotein ratio with extracranial and intracranial atherosclerotic stenosis[J]. Front Neurol, 2021, 12:756496. doi: 10.3389/fneur.2021.756496 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 25

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Li Zhiyong. Transient peripheral carotid inflammation syndrome diagnosed by ultrasonography: A case report and literature review [J]. Clinical Focus, 2023, 38(11): 1027-1030.
[2]	Zhang Lei, Lou Haidong, Zhi Yu, Qi Shuying. Efficacy and safety of PCSK9 inhibitors on atherosclerotic cardiovascular disease: A meta-analysis [J]. Clinical Focus, 2022, 37(12): 1074-1080.
[3]	Chen Jun, Zhou Yiwei, Li Xiujuan. Analysis of antithrombotic therapy for symptomatic lower extremity atherosclerosis disease [J]. Clinical Focus, 2021, 36(10): 937-941.
[4]	Xu Yaoming, Du Yanqiu, Miu Zhongrong, Gao Feng. Clinical analysis of endovascular recanalization for chronic intracranial segment of intracranial artery occlusion [J]. Clinical Focus, 2021, 36(1): 30-34.
[5]	. [J]. Clinical Focus, 2016, 31(4): 456-457.
[6]	. [J]. Clinical Focus, 2016, 31(1): 108-111.
[7]	Zhang Xueqiang;Wang Jianfeng. Application of multiple endovascular techniques in treatment of acute and chronic lower extremity arterial thrombosis [J]. Clinical Focus, 2015, 30(11): 1283-1287.
[8]	. [J]. Clinical Focus, 2015, 30(6): 680-682.
[9]	. [J]. Clinical Focus, 2015, 30(6): 682-683.
[10]	. [J]. Clinical Focus, 2015, 30(3): 339-340.
[11]	. [J]. Clinical Focus, 2015, 30(3): 341-344.
[12]	. @@ [J]. Clinical Focus, 2014, 29(12): 1423-1426.
[13]	. [J]. Clinical Focus, 2014, 29(7): 826-829.
[14]	. [J]. Clinical Focus, 2014, 29(7): 833-837.
[15]	. [J]. Clinical Focus, 2014, 29(5): 599-601.